BRAF V600E-Mutated Ganglioglioma of the Optic Pathway: A Case Report and Review of the Literature

Solomon, Alexander; Chia, Tao Ming Thomas; Juric-Sekhar, Gordana; Francis, Courtney E.

doi:10.1097/wno.0000000000001154

Journal of Neuro-Ophthalmology

2020

DOI: 10.1097/wno.0000000000001154

|View full text |Cite

BRAF V600E-Mutated Ganglioglioma of the Optic Pathway: A Case Report and Review of the Literature

Alexander Solomon¹,

Tao Ming Thomas Chia²,

Gordana Juric-Sekhar³

et al.

Abstract: Etoposide, temozolomide, imatinib, other agents. † Radiographic evidence of progression or clinical progression in terms of symptoms not malignant transformation. ‡ 4/18 total with follow-up; 1 case of death-teratoid/rhabdoid tumor that arose from a ganglioglioma in an 11-year-old.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

A rare tumor in the sellar region: ganglioglioma, a case report and a general overview

Erkan¹,

Demir²,

Akpınar³

et al. 2023

Childs Nerv Syst

View full text Add to dashboard Cite

Gangliogliomas are rare mixed neuronal-glial tumors of the central nervous system. They constitute less than 2% of intracranial neoplasms. Gangliogliomas are slow-growing, well-differentiated, and partly calci ed tumors. Sellar-suprasellar gangliogliomas are very rare [1]. Although many studies have included only cerebral hemisphere gangliogliomas, the tumor could not be classi ed according to its location because of the small number of patients in most studies [2].Herein, a rare case of a pediatric ganglioglioma in the sellar and parasellar region is presented with a histopathological diagnosis of ganglioglioma from a centre with an annual series of 150 endoscopic skull base surgeries and 900 endoscopic skull base surgeries.

show abstract

A rare tumor in the sellar region: ganglioglioma, a case report and a general overview

Erkan¹,

Demir²,

Akpınar³

et al. 2023

Childs Nerv Syst

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

BRAF V600E-Mutated Ganglioglioma of the Optic Pathway: A Case Report and Review of the Literature

Abstract: Etoposide, temozolomide, imatinib, other agents. † Radiographic evidence of progression or clinical progression in terms of symptoms not malignant transformation. ‡ 4/18 total with follow-up; 1 case of death-teratoid/rhabdoid tumor that arose from a ganglioglioma in an 11-year-old.

Cited by 1 publication

References 38 publications

A rare tumor in the sellar region: ganglioglioma, a case report and a general overview

A rare tumor in the sellar region: ganglioglioma, a case report and a general overview

Contact Info

Product

Resources

About